HIG
54
-8
AMG
57
-3
FRT
45
2
FSLR
49
-3
REGN
53
-3
MO
45
-2
ABT
30
-3
SIG
67
-5
PGR
40
3
PYPL
32
3
AMGN
39
-5
EQT
65
-3
TRV
42
5
PNC
59
3
TDC
63
3
AAP
26
-7
CA
15
6
SJM
19
2
VTR
63
6
PNW
69
2
HIG
54
-8
AMG
57
-3
FRT
45
2
FSLR
49
-3
REGN
53
-3
MO
45
-2
ABT
30
-3
SIG
67
-5
PGR
40
3
PYPL
32
3
AMGN
39
-5
EQT
65
-3
TRV
42
5
PNC
59
3
TDC
63
3
AAP
26
-7
CA
15
6
SJM
19
2
VTR
63
6
PNW
69
2
Financhill
Back

Avantis Short-Term Fixed Income ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
15

AVSF
Avantis Short-Term Fixed Income ETF

Last Price:
$46.87
Seasonality Move:
-0.64%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Sell
15
Avantis Short-Term Fixed Income ETF (AVSF) is a Sell

Is Avantis Short-Term Fixed Income ETF a Buy, Sell or Hold?

  • The current Avantis Short-Term Fixed Income ETF [AVSF] share price is $46.87. The Score for AVSF is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • AVSF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

AVSF Stock Price Chart

What is Avantis Short-Term Fixed Income ETF's stock price today?

  • The Avantis Short-Term Fixed Income ETF share price today is $46.87
    The current trend is relatively stagnant and AVSF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

AVSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 50.1 Buy
Chaikin Money Flow: 35809 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.65 - 47.09) Sell
Bollinger Bands (100): (46.89 - 47.23) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

AVSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.71 Buy
20-day SMA: 46.79 Buy
50-day SMA: 47.04 Sell
200-day SMA: 47.06 Sell
8-day EMA: 46.77 Buy
20-day EMA: 46.82 Buy
50-day EMA: 46.95 Sell
200-day EMA: 46.98 Sell

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

Avantis Short-Term Fixed Income ETF Earnings Growth & AVSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

Avantis Short-Term Fixed Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):